Source: Red Light Holland
  • Red Light Holland (TRIP) is now offering iMicrodose All-In-One Mushroom Fruiting Extracts for sale across Europe
  • The extracts will be available in both capsule and tincture formats on the iMicrodose website in October
  • SR Wholesale, Red Light Holland’s European distributor, provides products to over 1,000 retailers in the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal
  • Red Light Holland is an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles
  • Red Light Holland (TRIP) is currently up 2.13 per cent, trading at $0.24 per share

Red Light Holland (TRIP) is now offering iMicrodose All-In-One Mushroom Fruiting Extracts for sale across Europe.

The extracts are part of the iMicrodose product line powered by Red Light Holland, and will be available in both capsule and tincture formats on the iMicrodose website in October.

Todd Shapiro, CEO and director of Red Light Holland, commented on the new offering.

“Expanding our iMicrodose product offerings powered by Red Light Holland has always been a big part of our long term strategy to increase revenues and increase our brand exposure,” he said.

“Having these All-In-One Mushroom Fruiting Extracts in our product line up is very exciting as they allow us to reach out to SR Wholesale’s entire network,” he added. “And I love the eye catching labels!”

SR Wholesale, Red Light Holland’s European distributor, provides products to over 1,000 retailers in the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.

“Our team in the Netherlands are very proud to be so aggressive in this sector and we look forward to launching the iMicrodose All-In-One Mushroom products via SR Wholesale and soon online,” said Red Light Holland president Hans Derix.

Red Light Holland is an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles.

Its revenue is comprised of sales of wholesale truffles, cannabis seeds, and other cannabis products and sales of microdose packs.

Red Light Holland (TRIP) is currently up 2.13 per cent, trading at $0.24 per share as of 12:05 pm ET.

More From The Market Online

Psychedelic stock begins take-home LSD microdosing clinical trial

MindBio Therapeutics (CSE:MBIO) secures approvals for MB22001 – a form of LSD – microdosing use by patients in a controlled clinical trial.

Red Light Holland begins experimental research on psilocybin truffles

Red Light Holland has revealed that it has officially begun an experimental research project on its psilocybin truffles.
MindBio Therapeutics chief executive officer Justin Hanka.

Psychedelic stock clears hurdle to treating depression with LSD

Psychedelic stock MindBio (CSE:MBIO) is revealing positive top-line data from its pioneering microdosing clinical trial to treat depression.

Clearmind Medicine to begin alcohol use disorder clinical trial

Clearmind Medicine (CSE:CMND) has received approval to begin its phase I/IIa clinical trial for alcohol use disorder in Israel.